As we continue on our journey toward creating a safer environment for our patients, we are pleased to announce that the Baxter Sigma Spectrum Pump has been selected as our new large volume IV infusion pump.
Many factors have gone into this critical decision. Long-term vendor relationships, as well as flexibility to ensure we are looking at “best in class,” were primary drivers. The organization went through a lengthy and very involved process to ensure all potential vendors were fully vetted and that our final selection was deemed clinically acceptable by our clinicians.
The effort was led by a multidisciplinary group including Clinical Engineering, Nursing, CBIS, Supply Chain, Respiratory, Anesthesiology, Pharmacy and Support Services.
The process included reference calls, onsite presentations/demonstrations, hands-on evaluations and feedback from over 292 participants including Staff RN’s, Nurse Leaders, Respiratory Therapists, Anesthesiologists, Nurse Educators, Clinical Nurse Specialists, and Advanced Practice Nurses.
Now that the selection phase is complete, we will soon be officially kicking-off the implementation phase before the end of the year. That will include clinician involvement in building the drug libraries, testing and staff training.
The goal will be to have the new Baxter Sigma Spectrum IV pumps rolling-out on a demonstration unit by end of FY15.
Deployment of new infusion pumps is another step we are taking to improve UCM medication safety practices, which began with our roll-out of Barcoding Medication Administration (BCMA) in June 2014.
Both of these initiatives actively support our Annual Operating Plan (AOP) Quality and Safety objectives specifically: “To provide highly reliable, defect-free care that eliminates preventable harm, with a focus on medication safety”
DEBRA ALBERT, MSN, MBA, RN, NEA-BC
Senior Vice President, Patient Care Services and Chief Nursing Officer
Sally Walton, RN, MSN, MBA, RN, OCN, NEA-BC
Director of Nursing Technology & Innovation